A detailed history of Price T Rowe Associates Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 29,396 shares of CDNA stock, worth $438,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,396
Previous 27,052 8.66%
Holding current value
$438,000
Previous $325,000 4.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$7.96 - $12.37 $18,658 - $28,995
2,344 Added 8.66%
29,396 $312,000
Q4 2023

Feb 14, 2024

SELL
$4.9 - $12.86 $78,091 - $204,949
-15,937 Reduced 37.07%
27,052 $325,000
Q3 2023

Nov 14, 2023

BUY
$7.0 - $11.26 $47,873 - $77,007
6,839 Added 18.92%
42,989 $301,000
Q2 2023

Aug 14, 2023

BUY
$7.61 - $9.46 $35,310 - $43,894
4,640 Added 14.73%
36,150 $308,000
Q1 2023

May 15, 2023

SELL
$8.83 - $17.61 $2.09 Million - $4.16 Million
-236,291 Reduced 88.23%
31,510 $289,000
Q4 2022

Feb 14, 2023

SELL
$10.88 - $20.05 $1.52 Million - $2.81 Million
-139,962 Reduced 34.32%
267,801 $3.06 Million
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $10,952 - $17,997
-682 Reduced 0.17%
407,763 $6.94 Million
Q2 2022

Aug 15, 2022

SELL
$20.49 - $39.72 $6.63 Million - $12.9 Million
-323,737 Reduced 44.22%
408,445 $8.77 Million
Q1 2022

May 16, 2022

SELL
$28.19 - $46.6 $3.29 Million - $5.44 Million
-116,631 Reduced 13.74%
732,182 $27.1 Million
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $3.19 Million - $5.7 Million
77,404 Added 10.03%
848,813 $38.6 Million
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $498,516 - $775,291
-8,428 Reduced 1.08%
771,409 $48.9 Million
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $1.45 Million - $2.19 Million
-22,989 Reduced 2.86%
779,837 $71.4 Million
Q1 2021

May 17, 2021

SELL
$57.62 - $95.6 $35.5 Million - $58.8 Million
-615,515 Reduced 43.4%
802,826 $54.7 Million
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $58.8 Million - $109 Million
1,418,341 New
1,418,341 $103 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $797M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.